Intervention Review

Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease

  1. Sally Spencer1,*,
  2. Charlotta Karner2,
  3. Christopher J Cates3,
  4. David J Evans4

Editorial Group: Cochrane Airways Group

Published Online: 7 DEC 2011

Assessed as up-to-date: 3 AUG 2011

DOI: 10.1002/14651858.CD007033.pub3


How to Cite

Spencer S, Karner C, Cates CJ, Evans DJ. Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD007033. DOI: 10.1002/14651858.CD007033.pub3.

Author Information

  1. 1

    Lancaster University, Faculty of Health and Medicine, Lancaster, Lancashire, UK

  2. 2

    BMJ Group, BMJ Evidence Centre, London, UK

  3. 3

    St George's University of London, Population Health Sciences and Education, London, UK

  4. 4

    Hemel Hempstead Hospital, Thoracic Medicine, Hemel Hempstead, Herts, UK

*Sally Spencer, Faculty of Health and Medicine, Lancaster University, Bailrigg, Lancaster, Lancashire, LA1 4YD, UK. s.spencer1@lancaster.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 DEC 2011

SEARCH